ADT
32
4
CNP
52
-2
NRG
37
-2
UNM
70
2
F
42
2
KMB
33
2
GILD
58
2
ECL
54
-3
SRE
45
-2
M
55
7
AAP
32
2
STZ
40
-2
CA
32
3
YUM
45
2
STI
12
-7
KO
44
-2
MKC
51
-2
NI
70
2
EW
57
2
OI
30
5
ADT
32
4
CNP
52
-2
NRG
37
-2
UNM
70
2
F
42
2
KMB
33
2
GILD
58
2
ECL
54
-3
SRE
45
-2
M
55
7
AAP
32
2
STZ
40
-2
CA
32
3
YUM
45
2
STI
12
-7
KO
44
-2
MKC
51
-2
NI
70
2
EW
57
2
OI
30
5
Financhill
Back

Apollomics 10K Form

Sell
50

APLM
Apollomics

Last Price:
$10.49
Seasonality Move:
-4.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive APLM News And Ratings

See the #1 stock for the next 7 days that we like better than APLM

APLM Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $18.92
Price / Book: 0.56

Profitability

EPS (TTM): -15.00000
Net Income (TTM): $-57.1M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Apollomics Earnings Forecast

Key Apollomics Financial Ratios

  • The Interest Expense is -0.09% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

Apollomics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: APLM
Website: apollomicsinc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

APLM Technical Analysis vs Fundamental Analysis

Sell
50
Apollomics (APLM) is a Sell

Is Apollomics a Buy or a Sell?

  • Apollomics stock is rated a Sell
    The current Apollomics [APLM] share price is $10.49. The Score for APLM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.